未找到相关数据
Phase I/II study of regorafenib (rego) and pembrolizumab (pembro) in refractory microsatellite stable colorectal cancer (MSSCRC)
被引：38
作者：
Barzi, Afsaneh
Azad, Nilofer Saba
Yang, Yan
Tsao-Wei, Denice
Rehman, Rabia
Fakih, Marwan
Iqbal, Syma
El-Khoueiry, Anthony B.
Millstein, Joshua
Jayachandran, Priya
Zhang, Wu
Lenz, Heinz-Josef
机构：
[1] AccessHope, City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Johns Hopkins Sidney Kimmel Canc Ctr, Dept Oncol, Baltimore, MD USA
[3] Univ Southern Calif Angeles, Los Angeles, CA 90024 USA
[4] USC Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[7] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[8] USC Norris Comprehens Canc Ctr, Dept Prevent Med, Sch Med, Los Angeles, CA USA
[9] USC Keck Sch Med, Los Angeles, CA USA
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页数：3
相关论文